Teza Capital Management LLC Has $458,000 Stake in Waters Corporation $WAT

Key Points

• Teza Capital Management LLC reduced its position in Waters Corporation by 73% during the first quarter, now holding 1,243 shares valued at approximately $458,000.
• Noteworthy institutional investors making substantial purchases include GAMMA Investing LLC, which increased its stake by over 50,000%, and OVERSEA CHINESE BANKING Corp Ltd, which boosted its stake by 676.8% during the same period.
• Waters Corporation reported Q2 earnings of $2.95 per share, exceeding expectations and showing an 8.8% year-over-year revenue increase to $771.33 million.

Teza Capital Management LLC trimmed its position in Waters Corporation (NYSE:WAT - Free Report) by 73.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,243 shares of the medical instruments supplier's stock after selling 3,361 shares during the quarter. Teza Capital Management LLC's holdings in Waters were worth $458,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Lederer & Associates Investment Counsel CA grew its stake in Waters by 1.0% during the 1st quarter. Lederer & Associates Investment Counsel CA now owns 3,155 shares of the medical instruments supplier's stock worth $1,163,000 after buying an additional 30 shares during the last quarter. Integrated Wealth Concepts LLC lifted its holdings in shares of Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier's stock valued at $386,000 after buying an additional 30 shares during the period. FourThought Financial Partners LLC lifted its holdings in shares of Waters by 5.1% during the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier's stock valued at $243,000 after purchasing an additional 32 shares during the last quarter. Benjamin Edwards Inc. lifted its holdings in shares of Waters by 4.8% during the fourth quarter. Benjamin Edwards Inc. now owns 744 shares of the medical instruments supplier's stock valued at $276,000 after purchasing an additional 34 shares during the last quarter. Finally, MainStreet Investment Advisors LLC lifted its holdings in shares of Waters by 1.2% during the fourth quarter. MainStreet Investment Advisors LLC now owns 3,381 shares of the medical instruments supplier's stock valued at $1,254,000 after purchasing an additional 40 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Down 2.3%

WAT stock traded down $7.05 during mid-day trading on Friday, hitting $295.40. The stock had a trading volume of 326,673 shares, compared to its average volume of 570,240. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56. The company has a fifty day moving average of $299.65 and a 200 day moving average of $333.38. The stock has a market capitalization of $17.58 billion, a price-to-earnings ratio of 26.64, a PEG ratio of 2.82 and a beta of 1.07.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same period in the prior year, the firm posted $2.63 EPS. The business's revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, equities analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Scotiabank reaffirmed a "sector outperform" rating and set a $465.00 target price on shares of Waters in a report on Friday, July 11th. Bank of America increased their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. UBS Group reissued a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. Finally, Robert W. Baird reduced their price objective on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.